Spontaneous Intracranial Hypotension
7
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Greater Occipital Nerve Block for Spontaneous Intracranial Hypotension
Blind Versus Targeted Epidural Patch With Autologous Platelet-rich Plasma for Spontaneous Intracranial Hypotension
A Clinical Registry of Spontaneous Intracranial Hypotension
ONSD Changes and Treatment Response After Epidural Blood Patch in Spontaneous Intracranial Hypotension
Pathophysiology and Treatment of Cerebrospinal Hypotension Exploration Study
Spontaneous Intracranial Hypotension Treatment "SIHT"
Pituitary Function and Spontaneous Intracranial Hypotension